Umbilical Cord Milking Compared With Delayed Cord Clamping to Increase Plancental Transfusion in Preterm Infants Less Than 34 Weeks' Gestation Born by Cesarean Section. Randomised Clinical Trial

Corporacion Parc Tauli1 site in 1 country40 target enrollmentJuly 2014

ConditionsPremature Infant Umbilical Cord Milking Delayed Clamping

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Premature Infant
Sponsor: Corporacion Parc Tauli
Enrollment: 40
Locations: 1
Primary Endpoint: Haemoglobin
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine whether the umbilical cord milking in preterm infants born by cesarian section less than 34 weeks is more effective than delayed cord clamping to obtain higher levels of hemoglobin.

Registry

clinicaltrials.gov

Start Date

July 2014

End Date

March 2016

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Corporacion Parc Tauli

Responsible Party

Principal Investigator

Mònica Domingo Puiggròs

Medical Doctor

Corporacion Parc Tauli

Eligibility Criteria

Inclusion Criteria

•Preterm infants less than 34 weeks' gestation born by cesarean section

Exclusion Criteria

•Inability to obtain informed consent from the mother state
•Monochorionic-monoamniotic twin gestation
•Placenta abruption
•Uterine rupture
•Transplacental cesarean
•Hydrops fetalis

Outcomes

Primary Outcomes

Haemoglobin

Time Frame: 1 hour and 24 hours at born

g/dl

Secondary Outcomes

Number of concentrate hematies transfusion(participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months))
Total intensive care unit stay(Participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months))
Apgar Score(1 and 5 minutes)
Hematocrit(1 hour and 24 hours at born)
Arterial pressure(2, 6, 12, 24, 36 and 48 hours of life)
Orine volume(24 and 48 hours of life)
Use of vasopresors drugs(24 hours of life)
Intraventricular hemorrhage(participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months))
Bronchopulmonary dysplasia(participants will be followed for the duration of hospital stay (from 2 weeks up to 3 months))